SCI Abstract

search
+
Defining “Flares” in Atopic Dermatitis: A Narrative Review
Defining “Flares” in Atopic Dermatitis: A Narrative Review
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by fluctuating disease activity. Exacerbatio...
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Upadacitinib is an oral selective Janus kinase inhibitor approved to treat moderate-to-severe atopic dermatitis (AD) in ad...
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry
Atopic dermatitis (AD), a chronic systemic disease, can cause intense skin itching and negatively impact sleep, mood, and ...
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults
The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults
Atopic dermatitis (AD) significantly affects quality of life in patients of all ages and requires long-term treatment. Dup...
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma
Data are limited regarding the performance of staging systems for non-head and neck cutaneous squamous cell carcinomas (no...
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
This is a summary of the original article: “Efficacy and safety of delgocitinib cream in adults with moderate to sev...
Understanding Enthesitis in Psoriatic Disease: Insights and Implications
Understanding Enthesitis in Psoriatic Disease: Insights and Implications
Enthesitis represents a hallmark feature and central pathological process in psoriatic arthritis and has been proposed as ...
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials
Differences in atopic dermatitis (AD) prevalence, clinical presentation, and pathophysiology have been reported in differe...
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
Low-dose oral minoxidil has gained recognition as an off-label treatment for hair loss disorders, including androgenetic a...
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review
Acne vulgaris (acne) is a common dermatological condition that can profoundly affect psychosocial well-being. Health-relat...
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks
The efficacy and safety of once-daily roflumilast foam 0.3%, a potent phosphodiesterase 4 inhibitor, has been demonstrated...
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials
Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by intensely pruritic papulonodular lesions....
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis
Oral Janus kinase inhibitors (JAKi) have proven effective in the treatment of atopic dermatitis (AD) in multiple clinical ...
Cardiovascular Imaging in Psoriasis: A Critical Review of Current Evidence, Techniques, and Therapeutic Implications
Cardiovascular Imaging in Psoriasis: A Critical Review of Current Evidence, Techniques, and Therapeutic Implications
Psoriasis is a systemic inflammatory disease increasingly recognized for its association with elevated cardiovascular risk...
Menopause and Common Dermatoses: A Systematic Review
Menopause and Common Dermatoses: A Systematic Review
Menopause is a universal physiological transition, marked by a decline in estrogen, which has important effects on skin an...
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations
The effectiveness of Janus kinase (JAK) inhibitors in treating atopic dermatitis (AD) is well established. However, little...
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study
Atopic dermatitis (AD) is a chronic inflammatory skin condition that significantly impairs the quality of life. Recent adv...
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Tralokinumab, a first-in-class and second biologic approved for treating moderate-to-severe atopic dermatitis in adolescen...
Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China
Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China
There are limited data on clinical outcomes and prognosis factors for bullous pemphigoid (BP) at long-term follow-up. We a...
Photoaging: Current Concepts on Molecular Mechanisms, Prevention, and Treatment
Photoaging: Current Concepts on Molecular Mechanisms, Prevention, and Treatment
Photoaging is the consequence of chronic exposure to solar irradiation, encompassing ultraviolet (UV), visible, and infrar...
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
There is a need for long-term atopic dermatitis (AD) treatments that can effectively improve AD involvement of the head an...
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution
Nail psoriasis (NP) affects up to 90% and 86% of patients with cutaneous psoriasis and psoriatic arthritis, respectively, ...
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching
Vulvovaginal itching is a common yet often under-recognized condition affecting women across all age groups. Despite its p...
Clinical Mimickers Misdiagnosed as Pyoderma Gangrenosum
Clinical Mimickers Misdiagnosed as Pyoderma Gangrenosum
Pyoderma gangrenosum (PG) is a rare, ulcerative, neutrophilic dermatosis that can be challenging to diagnose. Diagnosis of...
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review
Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review
Ethnic differences of the clinicopathological characteristics in many immune-mediated skin diseases have been reported, in...
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts
Management of hidradenitis suppurativa (HS) can be challenging and often requires a multimodal approach with use of on- an...
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa
Patients with dystrophic epidermolysis bullosa have pathogenic variants in COL7A1, leading to skin fragility. Beremagene g...
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study
Psoriatic disease is a lifelong chronic illness for which there is no cure. It is well established that psoriasis leads to...
Treat-to-Target in Atopic Dermatitis
Treat-to-Target in Atopic Dermatitis
Atopic dermatitis is one of the most common inflammatory skin diseases among children and adults. Over the last 5 years, t...
Load More
format_indent_increase